Virtus Biotech Clinical Trials ETF (BBC) Dividend Yield, History & Forecast

Virtus Biotech Clinical Trials ETF (BBC) is an exchange-traded fund (ETF) listed on the New York Stock Exchange Arca. It pays a current dividend yield of 1.34% ($0.66 per share annually (TTM)). The most recent ex-dividend date was December 22, 2025, with payment scheduled for December 29, 2025. market capitalization is approximately $47M.

BBC fund composition

BBC holds 198 positions. It charges an expense ratio of 0.65%, and manages $47.8M.

Sector allocation

Healthcare100.0%Financial Services0.8%Cash & Others0.2%

Frequently Asked Questions about Virtus Biotech Clinical Trials ETF (BBC)

What is Virtus Biotech Clinical Trials ETF's dividend yield?
Virtus Biotech Clinical Trials ETF (BBC) pays a current trailing twelve-month dividend yield of 1.34%, which works out to $0.66 per share annually based on the most recent payout schedule.
When does Virtus Biotech Clinical Trials ETF pay distributions?
The most recent ex-dividend date was December 22, 2025. The next scheduled dividend payment date is December 29, 2025.
How many years has Virtus Biotech Clinical Trials ETF increased its dividend?
Virtus Biotech Clinical Trials ETF (BBC) has increased its dividend for 2 consecutive years.
What does Virtus Biotech Clinical Trials ETF invest in?
This exchange-traded fund (ETF) endeavors to match the capital appreciation and income generation of the LifeSci Biotechnology Clinical Trials Index, disregarding fees and expenses. The underlying index focuses on tracking the financial progress of a carefully chosen group of biotechnology firms engaged in clinical trials. It is important to note that, as of February 27, the fund's official name transitioned from Virtus LifeSci Biotech Clinical Trials ETF to Virtus Biotech Clinical Trials ETF.